Skip to main content
. 2023 Apr;52(4):732–740. doi: 10.18502/ijph.v52i4.12441

Table 2:

Serum lipids, renal function tests and inflammatory markers of the studied population

Characteristics T2DP (n = 197) Controls (n = 197) *P-value

X ± SD 95% CI X ± SD 95% CI
Serum lipids
Triglycerides (mmol/L) 1.81 ± 0.58 1.52 – 2.03 0.78 ± 0.31 0.69–0.82 0.008
Total cholesterol (mmol/L) 3.36 ± 0.27 3.07 – 3.62 3.34 ± 0.19 3.27 – 3.46 0.972
LDL-Cholesterol (mmol/L) 2.02 ± 0.41 1.74 – 2.36 1.53 ± 0.32 1.41 – 1.66 0.011
HDL-Cholesterol (mmol/L) 0.29 ± 0.08 0.22 – 0.35 0.65 ± 0.12 0.59 – 0.73 0.009
Renal function tests
Urea (mmol/L) 8.11 ± 2.42 7.05 – 8.89 4.91 ± 0.37 4.70 – 5.05 0.013
Uric acid (µmol/L) 351.6 ± 62.07 312.57 – 390.84 219.8 ± 34.63 204.09–237.02 0.015
Creatinine (µmol/L) 139.01 ± 27.53 113.28 – 173.92 74.11 ± 13.17 70.21 – 77.5 0.007
GFR (ml/min) 58.00 ± 12.57 41.55 – 76.01 107.39 ± 37.61 94.67 – 115.58 0.006
Albumin (g/L) 30.94 ± 5.13 23.62 – 41.05 59.17 ± 4.83 58.03 – 66.01 0.018
Inflammatory markers
Fibrinogen (g/L) 1.67 ± 0.34 1.60 – 1.87 1.23 ± 0.19 1.12 – 1.4 0.023
CRP (g/L) 1.42 ± 0.27 1.29 – 1.94 0.87 ± 0.12 0.8 – 0.97 0.019
*

P-value: significant difference between type 2 diabetic patients and controls using independent sample Student’s t-test; T2DP: type 2 diabetic patients; X: average; SD: standard deviation; CI: confidence interval, GFR: Glomerular filtration rate; CRP: C protein reactive